Stockreport

Vor Bio Announces $75 Million Private Placement with TCGX

Vor Biopharma Inc.  (VOR) 
PDF BOSTON, March 27, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, announced t [Read more]